Holding(s) in Company

Summary by AI BETAClose X

James Robert Kight has increased his holding in TheraCryf PLC, crossing a notification threshold on May 14, 2026. His total voting rights now stand at 3.32574%, representing 70,000,000 shares, up from a previous notification of 2.63427% or 56,100,000 shares. This acquisition of voting rights was the sole reason for the notification, with no financial instruments involved.

Disclaimer*

UK 100

Latest directors dealings